Detailled Information

Name of the Instrument/Tool Athens Insomnia Scale (AIS)
First Description

Soldatos CR, Dikeos DG, Paparrigopoulos TJ. Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria. J Psychosom Res. 2000 Jun;48(6):555-60

Year 2000
Domains
Concept of constructs Sleep
Population/Disease Generic
Originally developed for Sjögren's syndrome, Systemic Lupus Erythematosus (SLE)
Other rheumatic diseases
where can be applied (only if validated)
Rheumatoid Arthritis (RA)
Additional population with no rheumatic diseases Yes
Patients with cancer, chronic pain , kidney transplant
Language: Originally published in English
Available in Language Japanese, Spanish, Greek, Polish, Arabic, Chinese, Korean
REFERENCE IDENTIFICATION
Author/s Soldatos CR, Dikeos DG, Paparrigopoulos TJ
Title Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria
Journal J Psychosom Res
Year 2000
Vol 48
Num 6
Pages 555-60
Country Greece
Language English
Other references of interest
Link https://pubmed.ncbi.nlm.nih.gov/12932801/
Brief Description

The diagnostic validity of the Athens Insomnia Scale

Link https://pubmed.ncbi.nlm.nih.gov/33256097/
Brief Description

Evaluation of Severity Levels of the Athens Insomnia Scale Based on the Criterion of Insomnia Severity Index

Link https://pubmed.ncbi.nlm.nih.gov/33091275/
Brief Description

Measures of Sleep in Rheumatologic Diseases: Sleep Quality Patient‐Reported Outcomes in Rheumatologic Diseases

Instrument/Tool Translations References
Link https://pubmed.ncbi.nlm.nih.gov/21210225/
Brief Description

A Spanish version of the Athens Insomnia Scale

Link https://pubmed.ncbi.nlm.nih.gov/23910517/
Brief Description

Development and validation of the Japanese version of the Athens Insomnia Scale

Link https://pubmed.ncbi.nlm.nih.gov/21714210/
Brief Description

Validation of the Polish version of the Athens Insomnia Scale

DEVELOPER CONTACT INFORMATION
Correspondence to Constantin R. Soldatos
E-Mail egslelabath@hol.gr
Address Sleep Research Unit, Department of Psychiatry, Athens University Medical School, Athens, Greece
Website ---
Available ---
Links ---
DESCRIPTION OF THE INSTRUMENT
Type Of Measure Questionnaire
Brief Description

The AIS is a  psychometric instrument designed for simultaneously establishing the diagnosis of insomnia and measure its severity. It consists of eight items: The first five questions pertain to sleep onset, awakenings during the night, early-morning awakening, total sleep time, and sleep quality (criterion A of the International Classification of Diseases, 10th Revision [ICD-10] criteria for insomnia). The last three questions refer to well-being, functional capacity, and sleepiness during the day (criteria C and D of the ICD-10 requirements for insomnia)

A brief five-item version (AIS-5) is also available and contains only the first five items that correspond to nocturnal sleep quality but not daytime symptoms.

Number of Items The standard questionnaire is eight items
Range 0-24
Responses options/scale Yes
Each item is rated on a 4-point Likert scale, with 0 corresponding to “no problem” or “normal,” and a score of 3 corresponding to “serious problem” or “did not sleep at all.”
Developed for ---
PRACTICAL APPLICATION
Method of administration Self-administered
Recommendations to score

The eight responses are summed to calculate a total score, which ranges from 0 to 24.

Score Interpretation A higher score indicates greater insomnia symptoms
Cut-off points A cutoff score of 6 or higher is recommended to identify individuals with a diagnosis of insomnia
Cut-off points applied to ---
Smallest detectable change if described ---
Smallest detectable change applied to ---
Completion time by the patient 2-3 minutes
Scoring time by the assessor <1 minutes
Training to score Not necessary
Strengths Easy to use, Useful in clinical practice & research
Limitations ---
OTHER COMMENTS
Other Comments

The AIS has high face and construct validity for screening for insomnia by ICD-10 criteria and has high feasibility for implementation both clinically and in research. The precise cutoff at which sensitivity and specificity are maximized may differ by population, and it is unknown how well the AIS performs against more recent insomnia diagnostic criteria in the ICSD-3 or DSM-5. Additional studies in specific rheumatic diseases determining best cutoffs are still needed to improve generalizability of the AIS. For measuring severity of insomnia, there are insufficient data, particularly in rheumatological diseases, to support use of the AIS, and the responsiveness to change and MID are unknown.